Trial Profile
PSN 821 in obese or overweight patients with or without type 2 diabetes mellitus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Oct 2011
Price :
$35
*
At a glance
- Drugs PSN 821 (Primary)
- Indications Obesity; Overweight
- Focus Therapeutic Use
- 20 Oct 2011 New trial record
- 05 Oct 2011 Results presented at the 2011 Annual Meeting of the North American Association for the Study of Obesity.